Aethlon Medical (AEMD) Change in Accured Expenses (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Change in Accured Expenses came in at $362450.0 in Q1 2026, up 45.72% YoY from $248736.0 in Q1 2025, and up 186.7% on a QoQ basis from -$418055.0 in Q4 2025.
Aethlon Medical (AEMD) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 17 years of Change in Accured Expenses data on file, last reported at $362450.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 45.72% year-over-year to $362450.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$383384.0 (down 618.49% YoY) and the FY2026 annual result came in at -$383384.0, down 618.49% from the prior year.
- Change in Accured Expenses improved to $362450.0 in Q1 2026, from -$418055.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $540780.0 in Q1 2022 to a low of -$418055.0 in Q4 2025.
- A 5-year average of $5058.1 and a median of -$25892.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses slumped 1435.09% — and 2025, when it soared 1118.7%.
- Tracing AEMD's Change in Accured Expenses over 5 years: stood at $304572.0 in 2022, then tumbled by 108.5% to -$25892.0 in 2023, then tumbled by 1435.09% to -$397466.0 in 2024, then declined by 5.18% to -$418055.0 in 2025, then surged by 186.7% to $362450.0 in 2026.
- The last three Change in Accured Expenses figures came in at $362450.0 (Q1 2026), -$418055.0 (Q4 2025), and -$190287.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Aethlon Medical | 1.05 Mn | 1.05 Mn | - | -626,991.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -626,991.00 |
| Jun 30, 2026 | -626,991.00 |
| Mar 31, 2026 | 362,450.00 |
| Mar 31, 2026 | 362,450.00 |
| Dec 31, 2025 | -418,055.00 |
| Dec 31, 2025 | -418,055.00 |
| Sep 30, 2025 | -190,287.00 |
| Sep 30, 2025 | -190,287.00 |
| Jun 30, 2025 | -137,492.00 |
| Jun 30, 2025 | -137,492.00 |
| Mar 31, 2025 | 248,736.00 |
| Mar 31, 2025 | 248,736.00 |
| Dec 31, 2024 | -397,466.00 |
| Dec 31, 2024 | -397,466.00 |
| Sep 30, 2024 | -228,406.00 |
| Sep 30, 2024 | -228,406.00 |
| Jun 30, 2024 | 323,776.00 |
| Jun 30, 2024 | 323,776.00 |
| Mar 31, 2024 | 20,410.00 |
| Mar 31, 2024 | 20,410.00 |